• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 3. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 4. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 5. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Research Briefing on Carbamic acid, [2-[(2-hydroxyethyl)dithio]ethyl]-, 1,1-dimethylethyl ester (CAS: 877864-07-8)

Carbamic acid, [2-[(2-hydroxyethyl)dithio]ethyl]-, 1,1-dimethylethyl ester (CAS: 877864-07-8) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique dithioethyl and carbamate functional groups, has been the subject of recent studies due to its potential applications in drug development and biochemical modulation. The presence of the dithioethyl moiety suggests possible roles in redox regulation and thiol-disulfide exchange processes, which are critical in various biological systems.

Recent research has focused on the synthesis and characterization of this compound, as well as its potential as a building block for more complex molecules. A study published in the Journal of Medicinal Chemistry (2023) highlighted its utility in the development of prodrugs, particularly those targeting oxidative stress-related diseases. The tert-butyl ester group in the molecule enhances its stability, making it a suitable candidate for further chemical modifications and in vivo studies.

In addition to its synthetic applications, Carbamic acid, [2-[(2-hydroxyethyl)dithio]ethyl]-, 1,1-dimethylethyl ester has been investigated for its biochemical properties. A 2022 study in Bioorganic & Medicinal Chemistry Letters demonstrated its ability to act as a reversible thiol modifier, which could be exploited in the design of enzyme inhibitors or activators. This property is particularly relevant in the context of cysteine protease modulation, a target of interest in inflammatory and infectious diseases.

Further investigations have explored the compound's potential in targeted drug delivery systems. The dithioethyl linker can be cleaved under reducing conditions, such as those found in tumor microenvironments, making it a promising candidate for the development of redox-responsive drug conjugates. Preliminary in vitro studies have shown encouraging results, with enhanced drug release profiles observed in hypoxic conditions.

Despite these promising findings, challenges remain in the optimization of this compound for clinical applications. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed in future research. However, the unique chemical properties of Carbamic acid, [2-[(2-hydroxyethyl)dithio]ethyl]-, 1,1-dimethylethyl ester continue to make it a valuable tool in medicinal chemistry and a subject of ongoing investigation in the pharmaceutical industry.

• 67385-10-8(Di-Boc-Cystamine)
• 877865-47-9(Carbonochloridic acid,2-[[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]dithio]ethyl ester)
• 877864-10-3(Carbamic acid, [2-[[2-(nitrooxy)ethyl]dithio]ethyl]-, 1,1-dimethylethylester)
• 434313-81-2(13-Oxa-6,7-dithia-2,11-diazapentadecanoic acid, 14,14-dimethyl-12-oxo-, 1,1-dimethylethyl ester)
• 93790-49-9(tert-butyl N-[2-(2-aminoethyldisulfanyl)ethyl]carbamate;hydrochloride)
• 485800-26-8(t-Boc-Cystamine)
• 877864-09-0(Carbamic acid, [2-[(2-bromoethyl)dithio]ethyl]-, 1,1-dimethylethyl ester)
• 97314-11-9(8,9-Dithia-2,5,12,15-tetraazahexadecanedioic acid, 4,13-dioxo-, 1,16-bis(1,1-dimethylethyl) ester)
• 485800-27-9(Boc-NH-ethyl-SS-propionic acid)
• 67385-09-5(2-(Boc-amino)ethanthiol (>90%))